Lorcaserin, marketed under the brand name Belviq, was a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating serotonin...
24 KB (2,109 words) - 17:51, 13 August 2024
5-HT2C receptor agonist (section Lorcaserin)
derivatives, such as Lorcaserin (Figure 6) have been evaluated for their potency and selectivity for the 5-HT2C receptors. Lorcaserin is a very potent agonist...
48 KB (5,032 words) - 18:40, 8 March 2024
on the market, Belviq (lorcaserin), a weight-loss medication. The U.S. Food and Drug Administration (FDA) approved lorcaserin on June 27, 2012. The company...
9 KB (772 words) - 15:13, 7 August 2024
Michele (May 8, 2013). "Schedules of Controlled Substances: Placement of Lorcaserin Into Schedule IV". Federal Register. Drug Enforcement Administration....
24 KB (1,461 words) - 07:27, 6 May 2024
its potential for causing valvulopathies and pulmonary hypertension) Lorcaserin (withdrawn in the United States by the FDA due to an increased risk of...
18 KB (1,873 words) - 09:39, 20 July 2024
serotonin receptors in a region of the brain called the hypothalamus. Lorcaserin (Belviq) was FDA approved for weight loss but was withdrawn from the market...
53 KB (4,991 words) - 05:08, 21 July 2024
pFPP Tryptamines Others AL-38022A ALPHA Dimemebfe Efavirenz Glaucine Lorcaserin M-ALPHA RH-34 Also empathogens in general (e. g.: 5-APB, 5-MAPB, 6-APB...
166 KB (15,881 words) - 07:54, 15 August 2024
pFPP Tryptamines Others AL-38022A ALPHA Dimemebfe Efavirenz Glaucine Lorcaserin M-ALPHA RH-34 Also empathogens in general (e. g.: 5-APB, 5-MAPB, 6-APB...
118 KB (11,362 words) - 03:08, 29 August 2024
authorities rejected lorcaserin and phentermine-topiramate, in part because of associations of heart valve problems with lorcaserin and more general heart...
176 KB (18,782 words) - 06:40, 31 August 2024
methylergometrine (methylergonovine), pergolide) Flumexadol IHCH-7113 Jimscaline Lorcaserin MDxx (e.g., MDA (tenamfetamine), MDMA (midomafetamine), MDOH, MMDA) O-4310...
134 KB (12,303 words) - 05:26, 2 September 2024